STING1 and cancer: Agonists of STING such as c-di-GMP have been successfully used as cancer adjuvants, and cGAMP was proved to be effective in enhancing the anti-tumor effect when combined with radiotherapy and immune checkpoint inhibitors (ICIs) [53,56,57].